Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors
申请人:Allen Daniel Rees
公开号:US20120077815A1
公开(公告)日:2012-03-29
A series of amino-substituted fused pyridine and pyrazine derivatives, in particular amino-substituted quinoline and quinoxaline derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.